Biliopancreatic Diversion with Duodenal Switch in Patients with Type 2 Diabetes mellitus: Is the Chance of Complete Remission Dependent on Therapy and Duration of Insulin Treatment?

被引:9
|
作者
Cho, Eun-Young [1 ]
Kemmet, Olga [1 ]
Frenken, Michael [1 ]
机构
[1] St Josef Krankenhaus Monheim, Dept Surg, D-40789 Monheim, Germany
关键词
Biliopancreatic diversion with duodenal switch; BPD-DS; Type 2 diabetes mellitus; Complete remission; Insulin; OBESE-PATIENTS; SENSITIVITY; GLUCOSE; RESISTANCE; SURGERY; TERM;
D O I
10.1159/000327037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Rapid resolution of type 2 diabetes mellitus (T2DM) is a common feature after intestinal bypass surgery bypassing the duodenum and parts of the jejunum. However, the parameters determining the individual chance of remission are imprecisely defined. Methods: Biliopancreatic diversion with duodenal switch and sleeve gastrectomy (BPD-DS) was performed in n = 86 patients with T2DM (mean age 50 years, range 26-68, 51 females; BMI 47 kg/m(2), range 26-71). The patients were retrospectively divided into 4 groups according to the treatment modality and the duration of insulin treatment preoperatively: n = 18 patients were treated with oral antidiabetic drugs only (group 1); n = 32, n = 24, and n = 12 patients were treated with insulin for less than 5 years, for 5-10 years, and for more than 10 years (groups 2, 3, and 4), respectively. Results: At discharge from hospital, all patients of groups 1 and 2 were free of insulin usage, 30% and 75% of the patients of groups 3 and 4 used up to 48 units of insulin per day (mean 24, n = 16). After 1 year, only 4 patients of group 4 permanently required small amounts of insulin (mean 17 units per day) to keep blood glucose below 200 mg/dl. These 4 patients had been using insulin preoperatively for 13, 15, 22, and 25 years. In 3 of these 4 patients, fasting C-peptide was measured and found to be low (<1.2 ng/ml). The rate of complete remission of diabetes for the whole study population was 91%. Conclusion: BPD-DS reliably causes rapid and complete remission of T2DM in all patients on oral antidiabetic drugs and in patients with insulin treatment for less than 5 years. In patients with insulin treatment longer than 5 or 10 years, complete remission rates decline to 88 and 66%, respectively. A low C-peptide preoperatively might be a specific adverse prognostic parameter for the chance of diabetes remission.
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [41] Long-Term Glycemic Remission in Patients with Type 2 Diabetes Mellitus Treated with Insulin Pump Therapy
    Choi, Soo Bong
    Hong, Eun Shil
    Jeon, Eun Kyoung
    Kim, Kyung Jin
    An, Hyun Ju
    Noh, Yun Hee
    DIABETES, 2015, 64 : A271 - A271
  • [42] Biliopancreatic diversion with duodenojejunal exclusion associated with truncal vagotomy. A new proposal for type 2 diabetes mellitus treatment
    Alleotti, Edson
    Palma, Rogerio Tadeu
    Pinto Junior, Paulo Engler
    Bento, Jose Antonio
    Yonamine, Raquel
    Lopes Cardoso Campos, Andre Luiz
    Waisberg, Jaques
    ACTA CIRURGICA BRASILEIRA, 2012, 27 (08) : 577 - 584
  • [43] Insulin Therapy in Type 2 Diabetes Mellitus
    Leahy, Jack L.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2012, 41 (01) : 119 - +
  • [44] Insulin Therapy for Type 2 Diabetes Mellitus
    Wallia, Amisha
    Molitch, Mark E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (22): : 2315 - 2325
  • [45] Resolution of diabetes mellitus by ileal transposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes
    Zhang, Guang Yong
    Wang, Tian Tian
    Cheng, Zhi Qiang
    Feng, Jin Bo
    Hu, San Yuau
    CANADIAN JOURNAL OF SURGERY, 2011, 54 (04) : 243 - 251
  • [46] Combined metformin and insulin therapy for patients with type 2 diabetes mellitus
    Ponssen, HH
    Elte, JWF
    Lehert, P
    Schouten, JP
    Bets, D
    CLINICAL THERAPEUTICS, 2000, 22 (06) : 709 - 718
  • [47] Initiating basal insulin therapy in patients with type 2 diabetes mellitus
    Stoneking, K
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (05) : 510 - 518
  • [48] Challenges of optimizing insulin therapy for patients with type 2 diabetes mellitus
    Yen, Fu-Shun
    Hwu, Chii-Min
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (09) : 1523 - 1525
  • [49] INTENSIVE INSULIN THERAPY IN SURGICAL PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Komissarova, E. S.
    Belyaeva, N. G.
    Tezyaeva, S. A.
    Strongin, L. G.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2013, 5 (01) : 64 - 68
  • [50] Perception of insulin therapy in uncontrolled patients with type 2 diabetes mellitus
    Leyva Jimenez, Rafael
    Hernandez Zambrano, Gustavo
    Ibarra Maldonado, Silvia
    Ibarra Ramirez, Carlos Tomas
    ATENCION PRIMARIA, 2016, 48 (08): : 543 - 549